Company profile
Aerpio Pharmaceuticals company profile
Aerpio Pharmaceuticals is a new, clinical-stage biotechnology company focused on the development of novel small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Aerpio was created in a spin-out transaction from Akebia Therapeutics to enable more rapid development of its exciting compounds. It is managed by the same successful team from Akebia, employing a similar outsourced approach to pharmaceutical development. Aerpio Pharmaceuticals was founded in 2011 and is based in Cincinnati, Ohio, United States.
Business identity
- Website
- http://www.aerpio.com
- Phone number
- (513) 985-1924
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $10K+
- Founded
- 2011-01-01
Headquarters
- Headquarters
- Cincinnati, Ohio, United States
- Postal code
- 45242
- Country code
- US
- Continent
- North America